Clinical Trials Browser

Phase 1/2 × Carcinoma, Medullary × Imatinib Mesylate × Clear all

NCT00354523 2014-12-17

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Phase 1/2 Terminated

Thyroid Neoplasms, Carcinoma, Medullary